Skip to main content
Premium Trial:

Request an Annual Quote

Sure, It's Risky, But...

In the third installment of an essay on the risks and advantages of open access publishing, Cameron Neylon talks about the social issues surrounding the movement at Science in the open. While it's "unreasonable to expect the rapid adoption of new web based tools and even more unreasonable to expect scientists to change their overall approach to their research en masse," he says that a number of legitimate factors contribute to a lot of scientists' hesitation to embrace open access. Perceived cost, the risk that someone could scoop their data, and "simple inertia" are all driving factors. Check out his first and second installments on why we need open access and issues around the tools for doing open science.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.